Redmile Group, LLC
39 holdingsFiling period: 2026-06-30Current AUM: $1.21Bestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | SRRK | Scholar Rock Hldg Corp | 4.31M | $237.1M | $179.8M | 14.80% | -4,755,529 | 2026-06-30 |
| 2 | KRYS | Krystal Biotech Inc | 632.0K | $234.9M | $198.2M | 16.32% | -41,500 | 2026-06-30 |
| 3 | STOK | Stoke Therapeutics Inc | 3.95M | $129.1M | $100.5M | 8.27% | -218,200 | 2026-06-30 |
| 4 | IMNM | Immunome Inc | 4.91M | $104.1M | $87.9M | 7.23% | -647,295 | 2026-06-30 |
| 5 | NRIX | Nurix Therapeutics Inc | 4.07M | $98.8M | $104.1M | 8.57% | -3,659,021 | 2026-06-30 |
| 6 | ABSI | Absci Corporation | 6.74M | $78.1M | $63.7M | 5.24% | -1,513,641 | 2026-06-30 |
| 7 | ANNX | Annexon Inc | 11.87M | $67.8M | $43.9M | 3.62% | -2,679,891 | 2026-06-30 |
| 8 | RGNX | Regenxbio Inc | 4.37M | $52.3M | $28.7M | 2.37% | -- | 2026-06-30 |
| 9 | STTK | Shattuck Labs Inc | 6.89M | $47.8M | $38.2M | 3.14% | +1.35M | 2026-06-30 |
| 10 | NGNE | Neurogene Inc | 1.41M | $44.4M | $33.2M | 2.74% | -47,400 | 2026-06-30 |
| 11 | BEAM | Beam Therapeutics Inc | 1.16M | $40.0M | $27.7M | 2.28% | -73,400 | 2026-06-30 |
| 12 | AGMB | Agomab Therapeutics NV | 2.73M | $35.5M | $23.4M | 1.93% | +2.58M | 2026-06-30 |
| 13 | FATE | Fate Therapeutics Inc | 12.87M | $34.8M | $26.5M | 2.18% | -- | 2026-06-30 |
| 14 | IDYA | Ideaya Biosciences Inc | 640.2K | $23.9M | $21.0M | 1.73% | +119.1K | 2026-06-30 |
| 15 | SLN | Silence Therapeutics PLC | 2.16M | $23.8M | $42.8M | 3.52% | -- | 2026-06-30 |
| 16 | COGT | Cogent Biosciences Inc | 503.3K | $19.5M | $15.6M | 1.28% | -184,715 | 2026-06-30 |
| 17 | SLDB | Solid Biosciences Inc | 1.95M | $19.5M | $11.3M | 0.93% | -63,200 | 2026-06-30 |
| 18 | NUVB | Nuvation Bio Inc | 3.03M | $17.2M | $13.7M | 1.13% | -122,247 | 2026-06-30 |
| 19 | CLDX | Celldex Therapeutics Inc New | 433.9K | $16.1M | $12.8M | 1.05% | +172.4K | 2026-06-30 |
| 20 | CLYM | Climb Bio Inc | 1.23M | $16.0M | $10.8M | 0.89% | -- | 2026-06-30 |
| 21 | ALXO | Alx Oncology Hldgs Inc | 7.39M | $15.3M | $8.4M | 0.69% | -571,684 | 2026-06-30 |
| 22 | BMRN | Biomarin Pharmaceutical Inc | 265.2K | $15.2M | $14.8M | 1.22% | +91.3K | 2026-06-30 |
| 23 | XENE | Xenon Pharmaceuticals Inc | 229.4K | $13.8M | $8.2M | 0.68% | -33,300 | 2026-06-30 |
| 24 | ZYME | Zymeworks Inc | 491.7K | $12.9M | $13.9M | 1.15% | -- | 2026-06-30 |
| 25 | — | Adc Therapeutics SA | 11.53M | $12.3M | $12.3M | 1.02% | -3,943,792 | 2026-06-30 |
← Scroll →
Page 1 of 2